Immunomodulation of human NK cell activity by Marina Crystal Minerals (MCM), a crystallized mixture of minerals and trace elements from sea water

Nutrition Research

Volumn 19, Issue 9, 1999, Pages 1287-1298

  Ghoneum, Mamdooh ^a,b   Ogura, Takeshi ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Foundation for Basic Research of Oncology   (Japan)

Author keywords

Minerals; Natural killer activity; Trace elements

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; MARINA CRYSTAL MINERAL; MINERAL; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; SEA WATER; TRACE ELEMENT; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL FUNCTION; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

PHYTOLACCACEAE;

EID: 0033198991     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(99)00087-1     Document Type: Article

References (39)

1. Herberman, RB, Ortaldo, JR. Natural killer cells: Their role in defenses against disease. Science; 1981. 214:24-30.
2. Herberman, RB. NK Cells and Other Natural Effector Cells (Acad. Press, New York). 1982.
3. Herberman, RB, Thurman, GB. Summary of approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferon. J. Biol. Resp. Modif; 1983. 2:548-562.
4. Ghoneum, M. Gill, G., Wojdani, A., Payne, C. and Alfred, L. Suppression of basal and Corynebacterium parvum-augmented NK activity during chemically induced tumor development, Int. J. Immunopharm; 1987. 9:71-78.
5. Ghoneum, M., Ghonaim, M., Namatalla, G. et al. NK cell activity in hepatocellular carcinoma and its relation to the etiology of the disease. J. Clean Technol., Environ. Toxicol. & Occup. Med; 1996. 5,267-284.
6. Pross, HF., and Baines, MG. Spontaneous human lymphocyte-mediated cytoxicity against tumor target cells. I. The effect of malignant disease. Int. J. Cancer; 1976. 18:593-604.
7. Hersey, P., Edwards, A., and McCarthy, WH. Tumor-related changes in natural killer activity in melanoma patients. Influence of stage of disease, tumor thickness and age of patients. Int. J. Cancer; 1980. 25:187-194.
8. Takasugi, M., Ramseyer, A., Takasugi, J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977. 37:413-418.
9. Wilmer, LS., Bankhurst, AD., Jumonville, AJ., Saiki, JH, Saiers, JH, and Dobemeck, RC. Defects in natural cell activity and interferon response in human lung carcinoma and malignant melanoma. Cancer Res.; 1984. 44:852-856.
10. Powell, CB., Mutch, DG., Kao, MS., Kao, JW., Perry, DL., Westphale, E and Collins, JL. Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic (NC) activity. Cancer; 1990. 65, 466-472.
11. Powell, CB., Mutch, DG., Kao, MS., and Collins, JL. Reduced natural cytotoxic cell activity in patients receiving cisplatin-bared chemotherapy and in mice treated with cisplatin. Clin. Exp. Immunol.; 1990. 79:424-429.
12. Fletcher, MA, Baron, GC, Ashman, M., Fischi, MA., Limas, NG. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn. Clin. Immunol.; 1987. 5, 69-81.
13. Lichtenstein, A., Berek, JS., Bast, R.C., Spina, C., Hacker, N, Knapp, RC, Zighelboim, J. Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterim parvum. J. Biol. Response Modif; 1984. 3:371-378.
14. Wolfe, SA., Tracey, DE., Henney, CS. Induction of 'natural killer' cells by BCG. Nature. 1976. 262, 584-586.
15. Miyakoshi, H. and Aoki, T. Acting mechanisms of Lentinan on human-11 enhancement on non-specific cell-mediated cytotoxicity as an interferon inducer. Int. J. Immunopharmac.; 1984. 4, 373-379.
16. Yunoki, S., Tanaka, N., Hizuta, A., et al.: Enhancement of antitumor cytotoxicity of hepatic lymphocytes by oral administration of PSK. Int. J. Immunopharmacol.; 1994. 16, 123-130.
17. Ebina, T., and Murata, K. Antitumor effect of PSK at a distant site: Tumor-specific immunity and combination with other chemotherapeutic agents. Jpn. J. Cancer Res.; 1992. 83:775-82.
18. Suo, J., Tanaka, N., Hizuta, A., Yunoki, S., Orita, K. Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK. Acta Medica Okayama; 1994. 48: 237-42.
19. Wojdani, A. and Ghoneum, M. In vivo augmentation of natural killer cell activity by Candida albicans. Int. J. Immunopharmac.; 1987. 9:827-832.
20. Marconi, P., Scaringi, L., Tissi, L., Boccanera, M., Bistoni, F., Bonmassar, E. and Cassone, A. Induction of natural killer cell activity by inactivated Candida albicans in mice. Infect. Immun.; 1985. 50:297-303.
21. Vojdani, A., and Ghoneum, M. In vivo effect of ascorbic acid on ehnancement of human natural killer cell activity. Nutrition Res.; 1993. 13:753-764.
22. Einhorn, S., Blomgren, H., Strander, H. Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int. J. Cancer.; 1978. 22:405-409.
23. Fresa, KL, Murasko, DM. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells. Cancer Res.; 1986. 46:81-8.
24. Brunda, MJ., Bellantoni, D., Sulich, V. In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells. Int. J. Cancer.; 1987. 40:365-41.
25. Henny, CS., Kuribayashi, K. Kern, DE., Gillis, S. Interleukin-2 augments natural killer activity. Nature.; 1981. 291:335-339.
26. Itoh, K, Tilden, AB., Kumagai, K., Balch, CM. Leu11+lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL2)-induced activated killer (AK) cells. J. Immunol.; 1985. 134:802-807.
27. Trinchieri, G., Matsumoto-Kobayashi, M., Clark, SC., Seehra, J., London, L., Perussia, B. Response of resting human peripheral blood natural killer cells to interleukin 2. J. Exp. Med.; 1984. 160:1147-1169.
28. Borden, EC., Holland, JF., Dao, TL., Gutterman, JV., Wiener, L. Chang, YC., Patel, J. Leukocyte-derived interferon (alpha) in human breast carcinoma. The Am. Can. Soc. phase-II trial. Ann. Intern. Med.; 1982. 97:1-6.
29. Ernstoff, MS., Fusi, S., Kirkwood, JM. Parameters of interferon action. I. Immunological effects of whole cell leukocyte interferon (IFN-alpha) in phase I-II trails. J. Biol. Resp. Modif.; 1983. 2:528-539.
30. Golub, SH., Dorey, F., Hara, H., Morton, D. Burk, MW. Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell populations. J. Natn. Can. Inst.; 1982. 5:703-710.
31. Lotzova, E., Savary, CA., Quesada, JR., Gutterman, JU., Hersch, EM. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon. J. Natn. Cancer Inst.; 1983. 71:903-910.
32. Maluish, AE., Ortaldo, JR, Conlon, J., Sherwin, SA., Leavitt, R., Strong, DM., Weirnik, P., Oldham, RK., Herberman, RB. Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J. Immunol.; 1983. 131:503-507.
33. Sait, T., Ruffman, R., Welker, RD., Herberman, RB., Chirigos, MA. Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers. Cancer Immunol. Immunother.; 1985. 19: 130-135.
34. Talmadge, JE., Herberman, RB., Chirigos, MA., Maluish, AE., Schneider, MA., Adams, JS., Phillips, H., Thurman, GB., Varesio, L., Long, C., Oldham, RK., Wiltrout, RH. Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. J. Immunol.; 1985. 135:2483-2491.
35. Ghoneum, M. Anti-Hiv activity in vitro of MGN-3, an activated arabinoxylane from rice bran. Biochem. Bioph. Res. Comm.; 1998. 243:25-29.
36. Ghoneum, M. Enhancement of human natural killer cell activity by modified arabinoxylane from rice bran (MGN-3). Int. J. Immunotherapy. 1998. XIV, 89-99.
37. Ghoneum, M. and Namatalla, G. NK immunomodulatory function in 27 cancer patient by MGN-3, a modified arabinoxylane from rice bran. Abstract, Proceedings of the 87th Ann. Meeting of American Assoc. for Cancer Res. Wash. DC., Apr. 20-24.
38. Djeu, JY. Antibody-dependent cell mediated cytotoxicity and natural killer cell phenomenon. J. Am. Vet. Med. Assoc.; 1982. 181:1043-1048.
39. Djeu, JY. Production of interferon by natural killer cells. Clin. Immunol. Allergy.; 1983. 3:561-568.